Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Dexketoprofen/tramadol - Menarini Ricerche

Drug Profile

Dexketoprofen/tramadol - Menarini Ricerche

Alternative Names: Dexketoprofen trometamol/tramadol; Dexketoprofen trometamol/tramadol hydrochloride; Dexketoprofen/tramadol hydrochloride; Dexketoprofene/tramadolo; DKP.TRIS/TRAM; DKP.TRIS/TRAM.HCL; DKP/TRAM; DKP/TRAM.HCL; Lenizak; Skudex; Skudexa; Skudexum; Skudo; TRAM.HCL/DKP; TRAM.HCL/DKP.TRIS; TRAM/DKP; TRAM/DKP.TRIS; Tramadol hydrochloride/dexketoprofen; Tramadol hydrochloride/dexketoprofen trometamol; Tramadol/dexketoprofen; Tramadol/dexketoprofen trometamol

Latest Information Update: 15 May 2020

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Menarini Ricerche
  • Class Cyclohexanols; Dimethylamines; Nonsteroidal anti-inflammatories; Opioid analgesics; Phenylpropionates; Propylene glycols; Small molecules
  • Mechanism of Action Adrenergic uptake inhibitors; Cyclooxygenase inhibitors; Opioid mu receptor agonists; Serotonin uptake inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Marketed Acute pain

Most Recent Events

  • 15 May 2020 EudraCT2019-003656-37 - no updates, phase IV study drug is launched
  • 05 Feb 2019 Chemical structure information added
  • 26 Sep 2016 Interim efficacy data from two pivotal phase III trials in Post-operative pain presented at the 16th World Congress on pain (WCP-2016)
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Back to top